MeSH tree: C04.557.645.520
Radionuclide therapy delivered directly to an artery is safe and feasible for patients with advanced meningioma, according to new research published in the December issue of The Journal of Nuclear Medicine. In the first long-term ...
Dec 11, 2024
0
19
A mother says years of painful headaches and speech issues from brain tumors were caused by prolonged use of a Pfizer birth control shot, according to a lawsuit filed Nov. 14 in Nevada Federal District Court.
Nov 18, 2024
0
68
Researchers at Baylor College of Medicine and Washington University School of Medicine, St. Louis have identified clinical and genetic predictors of multiple recurrent meningiomas (MRMs), the most aggressive form of this ...
Oct 24, 2024
0
27
A radiopharmaceutical therapy that has successfully extended progression-free survival for patients with neuroendocrine tumors shows early promise for delivering similar benefits to patients with difficult-to-treat meningioma, ...
Sep 29, 2024
0
31
Investigators have demonstrated how molecular profiling tumors can be used to help predict treatment response and survival in patients with meningiomas, the most common type of primary brain tumor, according to a recent study ...
Sep 10, 2024
0
32
Drugs developed to fight blood and other cancers could also help improve the efficiency of radiotherapy in the most commonly diagnosed low-grade brain tumor in adults, a new study has found.
Jul 10, 2024
0
30
Patients with a genetic syndrome called NF2-related schwannomatosis (NF2-SWN) have tumors that develop on the covering of the brain or grow along the nerves in the brain, spinal cord, and/or other locations in the body.
Jun 24, 2024
0
52
A brain tumor can significantly affect a person's quality of life, not just length of life. In 2023, approximately 25,000 people living in the U.S. were diagnosed with a brain tumor. There are different types of brain tumors ...
Jun 7, 2024
0
28
Investigators have discovered new mechanisms underlying the diversity of characteristics within a single tumor, as well as treatment resistance, in the most common type of primary central nervous system tumor, according to ...
May 20, 2024
0
40
Prolonged use of certain progestogen hormone drugs is associated with an increased risk of developing a type of brain tumor known as an intracranial meningioma, finds a study from France published by The BMJ today.
Mar 27, 2024
0
211
